TipRanks
Go Ultimate75% OFF

Daniel Kaye Insider Profile

4 Followers

Daniel Kaye, Director at CME Group, holds 4.84K shares in CME Group (Ticker: CME), holds 48.53K shares in AllianceBernstein (Ticker: AB), holds 60.09K shares in Equitable Holdings (Ticker: EQH).

Daniel Kaye's Trading History

CME
CME Group
Jun 29, 2026DirectorUninformative Buy145.13K$1.48M
AB
AllianceBernstein
May 22, 2026DirectorUninformative Buy170.03K$1.65M
EQH
Equitable Holdings
May 21, 2026DirectorUninformative Buy185.02K$3.16M
FGPRQ
Ferrellgas Partners
Oct 05, 2015―Informative Buy98.00K$21.63K

You May Also Like

Daniel Kaye insider profile FAQ

What is the percentage of profitable transactions made by Daniel Kaye?
The percentage of profitable transactions made by Daniel Kaye is 27%.
What is the average return per transaction made by Daniel Kaye?
The average return per transaction made by Daniel Kaye is 17.90%.
What stocks does Daniel Kaye hold?
Daniel Kaye holds: CME, AB, FGPRQ, EQH stocks.
What was Daniel Kaye’s latest transaction?
Daniel Kaye’s latest transaction was an Uninformative Buy of $145.13K.
What was Daniel Kaye's most profitable transaction?
Daniel Kaye’s most profitable transaction was an Informative Buy of EQH stock on March 19, 2020. The return on the trade was 198.20%.
What is Daniel Kaye's role in CME Group?
Daniel Kaye's role in CME Group is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.